- No file added yet -
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II - Fig 4
figure
posted on 2019-01-15, 18:38 authored by Raban V. Jeger, Matthias Pfisterer, Deborah R. Vogt, Søren Galatius, Ulrik Abildgaard, Christoph Naber, Hannes Alber, Franz Eberli, David J. Kurz, Giovanni Pedrazzini, André Vuilliomenet, Daniel Weilenmann, Hans Rickli, Kim Wadt Hansen, Peter Rickenbacher, David Conen, Christian Müller, Stefan Osswald, Nicole Gilgen, Christoph KaiserCumulative incidence curves with 95% confidence bands for the competing events of non-CABG major bleeding (Fig 4A) and thrombotic event (Fig 4B) according to age dichotomized at 65 years. Note the significant differences in major bleedings indicated by the not overlapping confidence bands, but the non-significant differences in thrombotic events. CABG, coronary artery bypass graft.
